Indeed, a recent study elegantly showed a strong correlation between ERK1/2 activity and cervical disease progression, and highlighted the importance of ERK1/2 and AP-1 signalling for oncoprotein expression in both a life cycle model of HPV infection and using an oropharyngeal squamous cell carcinoma cell line [79]. The gene discussed is MAPK3; the disease is squamous cell carcinoma.